U.S. Department of Health and Human Services
Staff Search  
​​

If you plan to apply, Register Early.

Registration is required at eRA Commons and grants.gov and can take 4 weeks.​

Diabetic Urologic Disease

The Diabetic Urologic Disease program advances basic research on natural history studies and clinical trials.  Fundamental research addresses how diabetes affects the bladder, prostate, urinary tract, and lower reproductive system.  Program-supported work includes studies in human cells as well as in mammalian and nonmammalian model organisms.  Specific projects include studies that investigate the mechanisms of fibrosis and use noninvasive imaging techniques to assess fibrosis.  

Other work seeks to discover genes that protect people from or predispose them to diabetic uropathy and identify early markers of increased risk for this disease.

​​​​​​​​​​​​​
 

 NIDDK Staff

 
Deborah Hoshizaki, Ph.D.Kidney and Urogenital Development; Kidney and Urology Regeneration and Repair; Urology CentersZiya Kirkali, M.D.Clinical Urology; Urology Small Business
Christopher Mullins, Ph.D.Urology Cell BiologyTracy Rankin, Ph.D.Kidney and Urology Training; Diabetic Uropathy; Erectile Dysfunction; Urology Molecular Endocrinology; Urology HIV/AIDS

 

 Related Funding Opportunities

 
Posted DateTitleFull Announcement
9/4/2014Advancing Interventions to Improve Medication Adherence (R01) (Summary) PA-14-334
8/27/2014Consortium on Beta-cell Death and Survival (HIRN-CBDS) (UC4) (Summary) RFA-DK-14-021
8/26/2014Type 1 Diabetes Complications IMPACT Award (DP3) (Summary) RFA-DK-14-017
8/25/2014Identification of Novel Targets and Pathways Mediating Weight Loss, Diabetes Resolution and Related Metabolic Disease after Bariatric Surgery in Humans (R01) (Summary) RFA-DK-14-025
8/20/2014Limited Competition: Data Coordinating Center for Type 1 Diabetes TrialNet (UC4) (Summary) RFA-DK-14-507
View More Funding Opportunities

​The resources listed below include reagents, data, protocols, etc.  If you would like to utilize any of these resources, contact the person associated with the resource.
 

 Research Resources

 
Resource NameDescription
Action to Control Cardiovascular Disease Risk in Diabetes Follow-up Study
ACCORDION (sponsored by NHLBI) is a prospective, observational follow-up study of at least 8000 participants who were treated and followed in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial.  Treatment in ACCORD ended in 2009 and…
(Summary)
Action for Health in Diabetes
Look AHEAD is a 16-center, randomized clinical trial investigating the long-term health effects of an intensive lifestyle intervention designed to produce weight loss. Look AHEAD enrolled 5,145 overweight or obese participants with type 2 diabetes…
(Summary)
Diabetic Complications Consortium
The goal of the NIDDK-sponsored Diabetic Complications Consortium (DiaComp) is to foster communication and collaboration between investigator communities involved in complications research.  Toward this goal, DiaComp: (1) sponsors annual meetings in…
(Summary)
Multidisciplinary Approach to the Study of Chronic Pelvic Pain Research Network

To help better understand the underlying causes of the two most prominent chronic urological pain syndromes—interstitial cystitis/painful bladder syndrome (IC/PBS) and chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS)—the National Institute…

(Summary)
Type 1 Diabetes-Rapid Access to Intervention Development
Type 1 Diabetes-Rapid Access to Intervention Development (T1D-RAID): T1D-RAID is not accepting new applications at this time, but currently supports ongoing projects. The goal of T1D-RAID is to facilitate translation from the lab to the clinic of…
(Summary)

View Additional Research Resources

 

 NIDDK Active Trials in Diabetes

 
View related clinical trials from ClinicalTrials.gov.

 

 Related Study Sections

 
Study sections conduct initial peer review of applications in a designated scientific area. View related study sections from the NIH's Center for Scientific Review.​